Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ISLB 2021 | Balancing next generation sequencing in tissue biopsy and liquid biopsy in clinical practice

Natasha Leighl, MD, MMSc, FRCPC, Princess Margaret Cancer Center, Ontario, Canada, discusses how to balance next generation sequencing in tissue biopsy vs liquid biopsy in clinical practice, focusing on lung cancer. The use of effective molecular testing can lead to better use of targeted therapies, especially when a large range of genomic markers are tested for. Minimally-invasive tissue biopsies of lung cancer tumors result in small samples, which can pose problems for carrying out molecular testing. A further challenge for next generation sequencing is improving access to it. Prof. Leighl also compares the cost-effectiveness of tissue biopsies vs liquid biopsies and their most-likely subsequent treatment regimens. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.

Disclosures

Research funding (Insitution): Amgen, Array, Astra Zeneca, Bayer, BMS (pending), Eli Lilly, EMD Serono, Guardant Health, Inivata, MSD, Novartis, Pfizer, Roche, Takeda

Honoraria (CME, advisory): Amgen, BMS, EMD Serono, GlaxoSmithKline, MSD, Novartis, Puma Biotechnology, Sanofi Genzyme, Takeda

Travel support (CME lectures): AstraZeneca, Roche, Teva-Oncotest

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.